Fresenius Kabi
Norah Ibrahim AlSuhaibani currently serves as a Pharmacovigilance Specialist for the GCC Area at Fresenius Kabi, a position held since August 2023. Prior to this role, Norah worked as the QPPV at Alphapharma from June 2021 to July 2023 and was a Medical Affairs Officer at AJA Pharma from December 2019 to May 2021. Additionally, Norah contributed to societal development as a member of the Women’s Committee for Societal Development from May 2017 to January 2021 and provided consulting services to the Riyadh Youth Advisory Committee during the same period. Early experience includes a PharmD internship at Al Kharj Military Cooperation Hospital from June 2018 to May 2019 and holding the position of Student Advisory Council Secretary at Princess Nourah Bint Abdulrahman University while pursuing a Bachelor's degree in Pharmacy, which was completed in 2019.
This person is not in any teams
This person is not in any offices
Fresenius Kabi
16 followers
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies.